Dose-Dense Epirubicin and Cyclophosphamide (EC) Followed by Paclitaxel in Breast Cancer: Feasibility

Clinical trial NCT00617370 · COMPLETED

Trial details

NCT number: NCT00617370
Sponsor: Memorial Sloan Kettering Cancer Center
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Breast Cancer Adenocarcinoma of the Breast

Start date: 2004-11-01
Primary completion: 2005-07-01
Enrollment: 38

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.